SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Audrey Chen

Investor Relations Manager

Daniel Eichner

Partner

Sheng Ge

Partner

Benjamin Joffe

Partner

Kelly Kirkpatrick

Director of Investor Relations

Vivian Law

Senior Associate

Steve McCann

Chief Financial Officer & General Partner

Sean O'Sullivan

Founder & Managing General Partner

Duncan Turner

General Partner

Qiyu Wu

Operations Director

Past deals in Portugal

Criam

Seed Round in 2021
CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.

Criam

Seed Round in 2021
CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.

Maven Pet

Pre Seed Round in 2021
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in Porto, Portugal.

Misk

Seed Round in 2018
Misk is a restaurant-loving community that helps you decide where to dine or drink a glass based on the recommendations of your friends.

Nuada

Convertible Note in 2018
Nuada is a revolutionary hand function improving system, safe, light and small that was designed to be affordable and non-intrusive. Their solution uses thin, breathable, flexible and smart textiles that people can customize. It’s a unique enhancement technology that aims to be an everyday essential wearable that people even forget they are wearing.

Vetherapy

Seed Round in 2018
Vetherapy is a biotechnology company based in San Francisco, California, specializing in veterinary regenerative medicine and tissue engineering. Founded in 2015, the company develops stem cell therapy products for cats, dogs, and horses, aimed at accelerating wound healing and treating autoimmune and inflammatory diseases. Vetherapy emphasizes quality and safety in its processes, which include the isolation, expansion, and cryopreservation of stem cells, as well as the preparation of platelet-rich plasma. By providing veterinarians with access to a stem cell and PRP bank through their cryopreservation services, Vetherapy ensures that these therapeutic products are readily available for immediate use, addressing various clinical needs for animal patients.

Criam

Convertible Note in 2018
CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.

Nuada

Convertible Note in 2017
Nuada is a revolutionary hand function improving system, safe, light and small that was designed to be affordable and non-intrusive. Their solution uses thin, breathable, flexible and smart textiles that people can customize. It’s a unique enhancement technology that aims to be an everyday essential wearable that people even forget they are wearing.

B2 Holding ASA

Seed Round in 2017
B2Holding ASA provides debt solutions for banks and institutional vendors. The company’s portfolio of business consists of purchase, management, and collection of unsecured and secured non-performing loans. It services include debt purchase and collection, credit information third party debt collection, and consumer lending, as well as telemarketing and fraud prevention services. It principally operates in Norway, Sweden, Denmark, Finland, Estonia, Latvia, Lithuania, Poland, Croatia, Slovenia, Serbia, Montenegro, Bosnia-Herzegovina, Austria, the Czech Republic, Hungary, Spain, Portugal, Italy, France, Bulgaria, Romania, Greece, and Cyprus. B2Holding SAS was founded in 2011 and is headquartered in Oslo, Norway.

Nuada

Seed Round in 2017
Nuada is a revolutionary hand function improving system, safe, light and small that was designed to be affordable and non-intrusive. Their solution uses thin, breathable, flexible and smart textiles that people can customize. It’s a unique enhancement technology that aims to be an everyday essential wearable that people even forget they are wearing.

Criam

Convertible Note in 2016
CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.

Criam

Seed Round in 2016
CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.